Evrofarma SA (ATH:EVROF)
Greece flag Greece · Delayed Price · Currency is EUR
3.850
+0.020 (0.52%)
Feb 18, 2026, 10:54 AM EET

Evrofarma Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
45.7248.7645.3836.733.91
Revenue Growth (YoY)
-6.24%7.45%23.66%8.23%1.28%
Cost of Revenue
36.4941.739.5932.8628.92
Gross Profit
9.237.065.83.844.99
Selling, General & Admin
6.264.644.694.734.65
Other Operating Expenses
-1.11-1.24-1.15-1.12-1.14
Operating Expenses
5.153.43.543.613.51
Operating Income
4.083.662.260.231.48
Interest Expense
-1.19-1.32-0.84-0.78-0.82
Earnings From Equity Investments
-0.060.020.030.01
Other Non Operating Income (Expenses)
0-0.07-0.07-0.010.21
EBT Excluding Unusual Items
2.892.321.36-0.540.88
Gain (Loss) on Sale of Investments
--0--0.02-0.03
Gain (Loss) on Sale of Assets
---00.04
Asset Writedown
-0.390.160.30.29
Pretax Income
2.892.711.52-0.261.17
Income Tax Expense
0.610.510.10.10.12
Net Income
2.282.21.42-0.361.06
Net Income to Common
2.282.21.42-0.361.06
Net Income Growth
3.54%55.18%--574.52%
Shares Outstanding (Basic)
-14141414
Shares Outstanding (Diluted)
-14141414
Shares Change (YoY)
-0.05%-0.02%--
EPS (Basic)
-0.160.10-0.030.08
EPS (Diluted)
-0.160.10-0.030.08
EPS Growth
-55.11%--574.53%
Free Cash Flow
4.130.530.6-4.150.55
Free Cash Flow Per Share
-0.040.04-0.300.04
Dividend Per Share
-0.050---
Gross Margin
20.20%14.48%12.77%10.46%14.70%
Operating Margin
8.92%7.50%4.97%0.63%4.35%
Profit Margin
4.99%4.52%3.13%-0.97%3.12%
Free Cash Flow Margin
9.03%1.09%1.32%-11.31%1.63%
EBITDA
5.855.313.751.632.82
EBITDA Margin
12.79%10.89%8.26%4.45%8.31%
D&A For EBITDA
1.771.661.491.41.34
EBIT
4.083.662.260.231.48
EBIT Margin
8.92%7.50%4.97%0.63%4.35%
Effective Tax Rate
21.05%18.66%6.77%-9.80%
Advertising Expenses
-0.170.160.120.12
Source: S&P Global Market Intelligence. Standard template. Financial Sources.